Sang Haak Lee

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 127 citations · Full text

Asthma, Rheumatology, Allergy +9

Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways

Hyeon Hui Kang, In Kyoung Kim, Hye In Lee et al. · Biochemical and Biophysical Research Communications · 2017 · 108 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Immunology +31

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial

Nan Zhong, Tieying Sun, Chao Zhuo et al. · The Lancet Infectious Diseases · 2014 · 94 citations

Community-acquired Pneumonia, Pulmonary Care, Antibiotics +3

Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice

Chin Kook Rhee, Sang Haak Lee, Hyung Kyu Yoon et al. · Respiration · 2011 · 89 citations